Clinical Trial Update: Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Cadonilimab, LM-302, and S-1 with intraperitoneal paclitaxel for Claudin 18.2-positive gastric cancer with peritoneal metastas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer with Peritoneal Metastasis

Drugs mentioned

• Cadonilimab
• LM-302
• PACLITAXEL (PACLITAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastric Cancer Stage IV, Peritoneal Metastases | Phase 2 | Status: RECRUITING